NUVECTIS PHARMA, INC. (NVCT) Operating income 2021–2025
NUVECTIS PHARMA, INC. (NVCT) annual operating income history from SEC filings — each fiscal year as reported.
-$27.6MFY2025 · since FY2021: -$12.9M → -$27.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$27.6M | -38.9% |
| FY2024 | -$19.8M | +13.3% |
| FY2023 | -$22.9M | -19.0% |
| FY2022 | -$19.2M | -49.2% |
| FY2021 | -$12.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice